HomeCompareTLPFY vs MRK

TLPFY vs MRK: Dividend Comparison 2026

TLPFY yields 8.26% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TLPFY wins by $154.06M in total portfolio value
10 years
TLPFY
TLPFY
● Live price
8.26%
Share price
$28.73
Annual div
$2.37
5Y div CAGR
69%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$154.12M
Annual income
$136,968,000.06
Full TLPFY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — TLPFY vs MRK

📍 TLPFY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTLPFYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TLPFY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TLPFY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TLPFY
Annual income on $10K today (after 15% tax)
$702.51/yr
After 10yr DRIP, annual income (after tax)
$116,422,800.05/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, TLPFY beats the other by $116,414,471.64/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TLPFY + MRK for your $10,000?

TLPFY: 50%MRK: 50%
100% MRK50/50100% TLPFY
Portfolio after 10yr
$77.09M
Annual income
$68,488,899.10/yr
Blended yield
88.84%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

TLPFY
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
2.7
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TLPFY buys
0
MRK buys
0
No recent congressional trades found for TLPFY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTLPFYMRK
Forward yield8.26%2.76%
Annual dividend / share$2.37$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR69%32.7%
Portfolio after 10y$154.12M$56.8K
Annual income after 10y$136,968,000.06$9,798.13
Total dividends collected$152.75M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: TLPFY vs MRK ($10,000, DRIP)

YearTLPFY PortfolioTLPFY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,097$1,396.75$11,206$366.19+$891.00TLPFY
2$15,612$2,668.64$12,650$502.35+$3.0KTLPFY
3$22,145$5,439.84$14,407$694.19+$7.7KTLPFY
4$35,882$12,187.07$16,585$967.82+$19.3KTLPFY
5$69,583$31,189.39$19,342$1,363.89+$50.2KTLPFY
6$169,983$95,529.33$22,913$1,947.19+$147.1KTLPFY
7$550,471$368,588.43$27,662$2,823.89+$522.8KTLPFY
8$2,474,268$1,885,264.93$34,159$4,173.35+$2.44MTLPFY
9$16,031,531$13,384,063.99$43,337$6,308.80+$15.99MTLPFY
10$154,121,739$136,968,000.06$56,776$9,798.13+$154.06MTLPFY

TLPFY vs MRK: Complete Analysis 2026

TLPFYStock

Teleperformance SE, together with its subsidiaries, provides outsourced customer and citizen experience management, and related services in France and internationally. The company operates in two segments, Core Services and Digital Integrated Business Services, and Specialized Services. It offers customer and citizen care; technical support; and customer acquisition services, as well as back-office solutions and integrated services, including social media content moderation services and data labeling for automation solutions; and knowledge services in the field of analytics solutions, automated systems, and artificial intelligence. The company also manages business processes, as well as provides digital platform, consulting, and data analysis services; and business process outsourcing services for government agencies. In addition, it offers online interpreting services; visa application management and consulate services for government departments; online healthcare navigation and advocacy services; and accounts receivable credit management services. The company serves automotive, energy and utilities, insurance, public sector, technology, travel and hospitality, and banking and financial services, as well as healthcare, media, retail and e-commerce, crypto, cargo, telecom, and video games industries. Teleperformance SE was incorporated in 1910 and is headquartered in Paris, France.

Full TLPFY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this TLPFY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TLPFY vs SCHDTLPFY vs JEPITLPFY vs OTLPFY vs KOTLPFY vs MAINTLPFY vs JNJTLPFY vs ABBVTLPFY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.